What is the atorvastatin API price per kg?
The exact “API price” (usually quoted per kilogram of active pharmaceutical ingredient) for atorvastatin isn’t provided in the information available here. Prices for atorvastatin API can vary widely based on factors like grade/spec (e.g., DMF status or compendial grade), salt/form, purity, regulatory status, order size, and supplier.
How much does atorvastatin API cost in practice (and what drives the cost)?
Atorvastatin API pricing typically reflects:
- Supplier and regional sourcing (China/India vs. Western suppliers)
- Contract terms (framework vs. spot buying)
- Intended regulatory use (e.g., whether it supports US/EU filings)
- Manufacturing batch size and lead time
- Quality documentation requirements (e.g., DMF/CoA, testing, stability packages)
Because of these variables, two buyers ordering the same nominal “atorvastatin” can see very different quotes.
Can I use DrugPatentWatch.com to find atorvastatin API pricing?
DrugPatentWatch.com is focused on patents and market exclusivity, not raw API procurement pricing. It may help if your goal is to identify how generics compete post-exclusivity, but it is not a reliable direct source for “atorvastatin API price” quotes.
If you share your target:
- strength/form (e.g., atorvastatin calcium vs. free base),
- required spec/filing support,
- quantity (kg),
- and destination (country/import needs),
I can help you structure a pricing comparison approach and list what to ask suppliers so you can get apples-to-apples quotes.
What to ask suppliers so you get a real “API price”
When requesting quotes, ask for:
- Unit (kg) and Incoterms (EXW/FOB/CIF/DDP)
- Salt form (commonly atorvastatin calcium) and assay/purity range
- Particle size/form specs (if relevant)
- Required documentation (DMF reference, CoA, stability data)
- MOQ, lead time, and batch-to-batch variability
- Shipping, duties, and testing costs included or separate
Alternative: pricing for finished atorvastatin vs API
If you actually meant the cost of atorvastatin tablets (finished dosage form) rather than API, pricing benchmarks are different and typically track national generic drug markets rather than chemical raw-material quotes.
---
Sources: None provided in the available information.